SCHEMBL3517570

SCHEMBL3517570

CCOC(=O)c1c(-c2ccc(CCc3ccc(N)cc3)cc2)c2cccnc2n(O)c1=O

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 1/20 0.39
SLC11A2 P49281 1/20 0.39
MAPT P10636 3/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
PRKCZ Q05513 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
MAOB P27338 1/20 0.38
ELANE P08246 3/20 0.38
KDM4E B2RXH2 3/20 0.38
POLB P06746 1/20 0.38
FEN1 P39748 1/20 0.38
PDE4D Q08499 1/20 0.38
IDO1 P14902 1/20 0.37
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3514327 0.91 MEN1 (0.40) MEN1KMT2ASMN1; SMN2LMNASLC11A2
SCHEMBL3514518 0.88 MAOB (0.41) MEN1KMT2ASMN1; SMN2LMNASLC11A2
SCHEMBL3517498 0.80 ELANE (0.45) MEN1KMT2AALDH1A1MAOBELANE
SCHEMBL3518051 0.79 MEN1 (0.48) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL3515438 0.78 ADORA1 (0.34) MEN1KMT2ASMN1; SMN2LMNAMAOB
SCHEMBL3514525 0.77 ALDH1A1 (0.55) MEN1KMT2ASMN1; SMN2LMNAALDH1A1
SCHEMBL3516366 0.77 MEN1 (0.41) MEN1KMT2ASMN1; SMN2LMNASLC11A2
SCHEMBL3515441 0.74 MEN1 (0.38) MEN1KMT2ASMN1; SMN2LMNAMAPT
SCHEMBL3515865 0.73 MEN1 (0.42) MEN1KMT2ASMN1; SMN2LMNASLC11A2
SCHEMBL3519483 0.71 SMN1; SMN2 (0.47) MEN1KMT2ASMN1; SMN2LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS RNASEH1, RNASE1, RNASEL MEN1 3126/4885KMT2A 2764/4885SMN1; SMN2 1566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.